Citadel Advisors
GRCL

Citadel Advisors’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Citadel Advisors’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
2023
Q4 		$580K Buy
2022
Q2 		– Sell
2022
Q1 		$126K Buy
2021
Q4 		– Sell
2021
Q3 		$243K Sell
2021
Q2 		$526K Buy
2021
Q1 		$596K Buy